Merrimack Pharmaceuticals, Inc.
MACK
$0.02
Change (1 day)
$15.89
Year High
$11.53
Year Low
Categories
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Revenue of Merrimack Pharmaceuticals, Inc. (MACK)
Revenue in 2023 (TTM): $
According to Merrimack Pharmaceuticals, Inc.'s latest financial reports the company's current revenue (TTM) is $. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Merrimack Pharmaceuticals, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $ | $ | $-2,176,000 | $-1,169,000 | $-1,181,000 |
| 2022 | $ | $-445,000 | $-2,619,000 | $-1,541,000 | $-1,544,000 |
| 2021 | $ | $ | $-2,760,000 | $-2,452,000 | $-2,455,000 |
| 2020 | $ | $ | $-5,153,000 | $-3,014,000 | $-3,028,000 |
| 2019 | $ | $-2,228,000 | $-23,894,000 | $-22,740,000 | $-21,267,000 |
| 2018 | $ | $ | $-63,432,000 | $-68,462,000 | $-40,506,000 |
| 2017 | $ | $ | $-91,083,000 | $-118,403,000 | $472.03 M |
| 2016 | $144.27 M | $137.36 M | $-98,429,000 | $-153,518,000 | $-151,740,000 |
| 2015 | $89.26 M | $89.21 M | $-129,371,000 | $-147,787,000 | $-147,957,000 |
| 2014 | $102.76 M | $102.76 M | $-66,256,000 | $-83,559,000 | $-83,291,000 |
| 2013 | $47.79 M | $47.79 M | $-120,540,000 | $-130,685,000 | $-130,925,000 |
| 2012 | $48.92 M | $48.92 M | $-92,742,000 | $-91,754,000 | $-91,277,000 |
| 2011 | $34.22 M | $-66,415,000 | $-75,487,000 | $-79,676,000 | $-79,223,000 |
| 2010 | $20.31 M | $-37,973,000 | $-44,901,000 | $-50,159,000 | $-50,104,000 |
| 2009 | $2.15 M | $-35,510,000 | $-44,852,000 | $-52,475,000 | $-49,073,000 |